Bone Biologics (BBLGW) Total Debt (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Total Debt for 2 consecutive years, with $20.1 million as the latest value for Q3 2017.
- Quarterly Total Debt rose 34.34% to $20.1 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $20.1 million through Sep 2017, up 34.34% year-over-year, with the annual reading at $8.8 million for FY2016, N/A changed from the prior year.
- Total Debt for Q3 2017 was $20.1 million at Bone Biologics, up from $19.1 million in the prior quarter.
- The five-year high for Total Debt was $20.1 million in Q3 2017, with the low at $8.8 million in Q4 2016.